| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |